Inovio Pharmaceuticals (INO) Short Interest
Nasdaq • INO • US45773H4092
As of Oct 27, 2026, ORTEX estimated 13% of free float sold short, 5.5 days to cover, cost to borrow 2.69%. Sign up for live short interest data.
Nasdaq • INO • US45773H4092
As of Oct 27, 2026, ORTEX estimated 13% of free float sold short, 5.5 days to cover, cost to borrow 2.69%. Sign up for live short interest data.
This page tracks how heavily Inovio Pharmaceuticals (Nasdaq:INO) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Inovio Pharmaceuticals (Nasdaq: INO) has a market capitalization of $265.87M. Last close $1.48 (as of 2026-11-12); 52-week range $0.56 to $2.72. ORTEX data as of 2026-10-27: short interest was 13.02% of free float, 5.5 days to cover and the average cost to borrow was 2.69%. Sign up for live short interest data.